期刊文献+

1,25-(OH)_2D_3对糖尿病大鼠ZO-1表达的影响 被引量:5

Effects of 1,25-Dihydroxyvitamin D_3 on the Expression of ZO-1 in the Kidney of Diabetic Rats
下载PDF
导出
摘要 目的观察糖尿病(DM)大鼠肾小球ZO-1蛋白的表达,1,25-(OH)2D3对ZO-1蛋白表达及分布的影响。方法Wistar大鼠随机分为3组:对照组、糖尿病组(DM组)、1,25-(OH)2D3组。链脲菌素(STZ)腹腔注射建立糖尿病动物模型,1,25-(OH)2D3组在糖尿病建立时即开始渗透性微量泵按3ng/100g·d皮下给予1,25-(OH)2D3,给药10周处死小鼠,检测血糖、半胱氨酸蛋白酶抑制剂(CysC)、尿红细胞、24h尿蛋白定量(24hUPE);光镜观察肾小球细胞数,细胞外基质(ECM)聚积;Western印迹检测ZO-1蛋白的表达;免疫金荧光染色电镜观察肾小球ZO-1分布的改变。结论DM组大鼠CysC、尿红细胞、24hUPE均高于1,25-(OH)2D3组,差异均有统计学意义(P<0.05)。1,25-(OH)2D3组大鼠较DM组肾小球细胞数减少,细胞外基质聚积减轻(P<0.05或P<0.01)。Western印迹示1,25-(OH)2D3组和对照组肾小球ZO-1表达无显著差异,均明显高于DM组(P<0.01)。免疫金荧光染色显示DM组肾小球ZO-1表达缺失及易位分布明显,1,25-(OH)2D3组ZO-1的表达缺失及易位分布较轻。结论1,25-(OH)2D3可减少尿蛋白的排泄,抑制肾小球细胞数及细胞外基质的增殖,增加足细胞特异蛋白ZO-1的表达,减少其易位,对肾脏有保护作用。 Aim To observe the effects of 1,25-(OH)2D3 on glomerular ZO-1 expression and distribution in the glomeruli of diabetic rats. Methods Wistar rats were randomly divided into the control group, diabetes group (DM group ), and 1,25-(OH)2D3 ( 1,25- ( OH ) 2 D3 group). Diabetes was induced by peritoneal injection of streptozotocin (STZ). Treatment with 1,25-(OH)2D3 ( 3 ng/100g·d) started on the diabetic model by subcutaneous implantation of osmotic minipumps in 1,25-( OH)2D3 group. After administration of 1,25-( OH)2D3 for 10 weeks, the rats were sacrificed, blood sugar ( BG), cystatin C ( Cys C ) , haematuria, 24-hour urinary protein excretion ( 24hUPE ) were measured. Glomerular cells and extracellular matrix (ECM) were observed by light microscope. The expression level of ZO-1 was examined by western blot. The distribution of ZO-1 in glomeruli after immunogold fluorescent staining was observed by electron microscopy. Results Compared with 1,25- (OH)2D3 group, Cys C, haematuria ,24hUPE in DM group were significantly increased ( P 〈 0.05 ). Glomerular cells and the accumulation of ECM in 1,25- (OH) 2D3 group were lower than those in DM group( P 〈 0.05 or P 〈 0.01 ). There was not significant difference in the expression of glomerular ZO-1 between control group and 1,25-( OH)2D3 group, whereas the expression of glomerular ZO-1 in control group and 1,25- (OH)2 D3 group was higher than that of DM group ( P 〈 0.01 ). Histologically ,obvious absence and translocation of the expression of ZO-1 in glomeruli were seen in DM group by immunogold fluorescent staining. The changes were attenuated in 1,25-( OH)2D3 group. Conclusion 1,25-(OH)2D3 could decrease the excretion of proteinuria, inhibit glomerular cells and ECM proliferation, significantly increase the expression and reduce translocation of ZO-1 to protect kidney in diabetic rats.
出处 《解放军药学学报》 CAS 2008年第1期26-29,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 糖尿病 1 25-(OH)2D3 ZO-1 Diabetes 1,25-(OH)2D3 ZO-1
  • 相关文献

参考文献12

  • 1Rincon-Choles H, Vasylyeva TL, Pergola PE, et al. ZO-1 Expression and Phosphorylation in Diabetic Nephropathy [ J]. Diabetes, 2006,55(4) : 894
  • 2王文姬,陈楠.活性维生素D_3与肾脏病[J].肾脏病与透析肾移植杂志,2006,15(3):262-265. 被引量:12
  • 3Kuhlmarnn A,Haas CS,Gross ML, et al. 1,25-Dihydmxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat[J]. Am J Physiol Renal Physiol ,2004,286(3) : F526
  • 4Hirata M, MakibayashiK, Katsumata K, et al. 22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats [J]. Nephrol Dial Transplant ,2002,17(12): 2132
  • 5邹敏书,何威逊.糖尿病肾病诊治进展[J].临床儿科杂志,2007,25(6):515-517. 被引量:4
  • 6Macconi D,Bonomelli M,Benigni A, et al. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury[J]. Am J Pathol, 2006,168 ( 1 ) :42
  • 7Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomemlar capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy[J]. Diabetes ,2005,54(6) : 1626
  • 8Saleem M, Ni L, Witherden I, et al. Co-localization of nephrin, podocin, and the actin cytoskeleton : evidence for a role in podocyte foot process formation [ J ]. Am J Pathol ,2002,161 (10) : 1459
  • 9Reiser J,Kriz W,Kretzler M, et al. The glomerular slit diaphragm is a modified adherens junction[J]. J Am Soc Nephrol ,2000,11(1) :1
  • 10范青锋,邢燕,丁洁.足细胞裂孔隔膜与信号传导[J].中华肾脏病杂志,2006,22(5):312-315. 被引量:5

二级参考文献83

  • 1Tryggvason K, Wartiovaara J. How does the kidney filter plasma? Physiology (Bethesda), 2005, 20: 96-101.
  • 2Ruotsalainen V, Ljungberg P, Wartiovaara J, et al. Nephrin is specifically located at the slit diaphragm of glomerular pedocytes. Proc Natl Acad Sci U S A, 1999, 96: 7962-7967.
  • 3Roselli S, Gribouval O, Boute N, et al. Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol, 2002,160: 131-139.
  • 4Wolf G, Stahl RA. CD2-associated protein and glomer ulazdisease. Lancet, 2003, 362(9397): 1746-1748.
  • 5Donoviel DB, Freed DD, Vogel H, et al. Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHPIN. Mol Cell Bid, 2001, 21:4829 -4836.
  • 6Schnabel E, Anderson JM, Farquhar MG. The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium. J Cell Biol, 1990, 111 : 1255-1263.
  • 7Inoue T, Yaoita E, Kurihara H, et al. FAT is a component of glomerular slit diaphragms. Kidney Int, 2001, 59: 1003-1012.
  • 8Schwarz K, Simons M, Reiser J, et al. Pedocin, a raft-associated component of the glomerular slit diaphragm,interacts with CD2AP and nephrin. J Clin Invest, 2001,108 : 1621-1629.
  • 9Roselli S, Heidet L, Sich M, et al. Early glomerular Filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol, 2004, 24: 550-560.
  • 10Koop K, Eikmans M, Baelde HJ, et al. Expression of pedocyte-associated molecules in acquired human kidney diseases. J Am Sot: Nephrol, 2003, 14: 2063-2071.

共引文献18

同被引文献54

  • 1甘良英,于仲元,蔡美顺,赵慧萍,李欣.低分子质量肝素对糖尿病肾病大鼠肾血管内皮生长因子表达的影响[J].北京大学学报(医学版),2005,37(4):382-385. 被引量:7
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8227
  • 3Mundel P, Shankland SJ. Podocyte biology and response to injury [J]. J Am Soc Nephrol ,2002,13(12) :3005
  • 4Calkin AC, Giunti S, Jandeleit-Dahm KA, et al. PPAR-α and -γ agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse [ J ]. Nephrol Dial Transplant , 2006,21 ( 9 ) : 2399
  • 5Nakamura T, Ushiyama C, Hirokawa K, et al. Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis [ J ]. Nephrol Dial Transplant ,2002,17 (5) :798
  • 6Regoli M, Bendayan M. Alterations in the expression of the alpha3 betal integrin in certain membrane domains of the glomerular epithetlial ceils (podocytes) in diabetes mellitus[J]. Diabetologia , 1997 ,40 : 15
  • 7Bjomson Granqvist A, Ebefors K, Saleem MA, et al. Podocyte proteoglyean synthesis is involved in the development of nephrotic syndrome [ J ]. Am J Physiol Renal Physiol ,2006,291 (4) : F722
  • 8Topham P, Barratt J, FeehaUy J. A spoonful of sugar helps the proteinuria go down [ J ]. Nephrol Dial Transplant , 2008,23 ( 3 ) : 813
  • 9Benck U, Haeckel S, Clorius JH, et al. Proteinuria-lowering effect of heparin therapy in diabetic nephropathy without affecting the renin-angiotensin-aldosterone system [ J ]. Clin J Am Soc Nephrol, 2007,2( 1 ) :58
  • 10Pecly IM, Goncalves RG, Rangel EP, et al. Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and TGF-β, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration [ J ]. Nephrol Dial Transplant ,2006,21 ( 5 ) : 1212

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部